New directions in incidence and prevalence of diagnosed diabetes in the USA.
adult diabetes
incidence
public health/surveillance
Journal
BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391
Informations de publication
Date de publication:
2019
2019
Historique:
received:
22
01
2019
revised:
20
03
2019
accepted:
20
04
2019
entrez:
28
6
2019
pubmed:
28
6
2019
medline:
28
6
2019
Statut:
epublish
Résumé
To determine whether diabetes prevalence and incidence has remained flat or changed direction during the past 5 years. We calculated annual prevalence and incidence of diagnosed diabetes (type 1 and type 2 combined) for civilian, non-institutionalized adults aged 18-79 years using annual, nationally representative cross-sectional survey data from the National Health Interview Survey from 1980 to 2017. Trends in rates by age group, sex, race/ethnicity, and education were calculated using annual percentage change (APC). Overall, the prevalence of age-adjusted, diagnosed diabetes did not change significantly from 1980 to 1990, but increased significantly (APC 4.4%) from 1990 to 2009 to a peak of 8.2 per 100 adults (95% CI 7.8 to 8.6), and then plateaued through 2017. The incidence of age-adjusted, diagnosed diabetes did not change significantly from 1980 to 1990, but increased significantly (APC 4.8%) from 1990 to 2007 to 7.8 per 1000 adults (95% CI 6.7 to 9.0), and then decreased significantly (APC -3.1%) to 6.0 (95% CI 4.9 to 7.3) in 2017. The decrease in incidence appears to be driven by non-Hispanic whites with an APC of -5.1% (p=0.002) after 2008. After an almost 20-year increase in the national prevalence and incidence of diagnosed diabetes, an 8-year period of stable prevalence and a decrease in incidence has occurred. Causes of the plateauing and decrease are unclear but the overall burden of diabetes remains high and deserves continued monitoring and intervention.
Identifiants
pubmed: 31245008
doi: 10.1136/bmjdrc-2019-000657
pii: bmjdrc-2019-000657
pmc: PMC6557467
doi:
Substances chimiques
Biomarkers
0
Blood Glucose
0
Types de publication
Journal Article
Langues
eng
Pagination
e000657Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JAMA. 2015 Sep 8;314(10):1021-9
pubmed: 26348752
JAMA. 2014 Sep 24;312(12):1218-26
pubmed: 25247518
MMWR Morb Mortal Wkly Rep. 2017 Jun 30;66(25):657-662
pubmed: 28662018
Am J Clin Nutr. 2013 Jul;98(1):180-8
pubmed: 23676424
Diabetes Care. 2017 Oct;40(10):1331-1341
pubmed: 28500215
Diabetes Care. 2018 Sep;41(9):1835-1838
pubmed: 30135196
N Engl J Med. 2017 Apr 13;376(15):1419-1429
pubmed: 28402773
JAMA. 2016 Jun 7;315(21):2284-91
pubmed: 27272580
Lancet. 2018 Jun 16;391(10138):2430-2440
pubmed: 29784146
Diabetes Care. 2017 Sep;40(9):1139-1143
pubmed: 28830954